PUBLISHER: Inkwood Research | PRODUCT CODE: 1348091
PUBLISHER: Inkwood Research | PRODUCT CODE: 1348091
The Europe retinal imaging devices market is expected to record a CAGR of 5.85% during the forecast period, 2023-2032. The stringent regulatory framework in Europe serves as a safeguard for the safety and effectiveness of medical equipment. Adherence to these regulations is paramount in guaranteeing the excellence of retinal imaging devices for both healthcare practitioners and patients.
Belgium, Italy, Poland, the United Kingdom, Spain, France, Germany, and Rest of Europe are assessed for the Europe retinal imaging devices market growth evaluation. The escalation in the prevalence of eye diseases, particularly age-related conditions like AMD and diabetic retinopathy, can be attributed to several factors, including an aging population and evolving lifestyle choices. As highlighted by the UK Census 2021, the demographic shift is evident, with the number of individuals aged 65 and older increasing from 9.2 million in 2011 to over 11 million in 2021. Additionally, the proportion of people aged 65 and above has risen from 16.4% to 18.6%. This demographic shift underscores the growing demand for precise disease assessment, thereby fueling the introduction of enhanced retinal imaging devices capable of facilitating accurate and early diagnosis.
Further, the continuous advancement in retinal imaging technology has paved the way for the development of more sophisticated equipment. Notably, OCT and fundus photography systems have made significant strides, offering higher resolution, quicker scans, and deeper insights into retinal architecture. Furthermore, the emergence of handheld and portable technologies has expanded access to remote and underserved areas, ultimately enhancing the quality of patient care.
Some of the leading companies in the market are: Optos plc, Carl Zeiss Meditec AG, Canon Inc, etc.